VAERS reports by lot

Moderna COVID-19 lot 007J21-2A: VAERS reports

198 VAERS reports list lot 007J21-2A as a Moderna COVID-19 vaccine, received between 2022-01-12 and 2024-05-29. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
198
Reports
9%
Marked serious
2
With a death outcome
14
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)7722%
Neurological7020%
Gastrointestinal3711%
Musculoskeletal3310%
Injection-site / Local reaction268%
Cardiac / Cardiovascular226%
Dermatological (non-injection-site)226%
Allergic / Anaphylactic216%
Respiratory144%
Thrombotic / Hematological113%
Psychiatric / Neuropsychiatric62%
Autoimmune / Immune-mediated21%
Reproductive / Menstrual21%

Where reports came from

U.S. state of the reporter, where given (top 12).

Pennsylvania22
California21
Texas14
Oregon14
Arkansas10
Kansas8
Minnesota7
Arizona6
Washington6
Wisconsin6
Florida5
Georgia5

Reports by month received

2022-0136
2022-0264
2022-0318
2022-0457
2022-054
2022-063
2022-075
2022-083
2022-091
2022-123
2023-011
2023-021
2023-061
2024-051

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.